Abstract
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics results of a long-acting C-type natriuretic peptide prodrug, TransCon CNP
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have